Metenkefalin
- Generic Name
- Metenkefalin
- Drug Type
- Small Molecule
- Chemical Formula
- C27H35N5O7S
- CAS Number
- 58569-55-4
- Unique Ingredient Identifier
- 9JEZ9OD3AS
Overview
Metenkefalin is an endogenous opioid and beta-endorphin. It has been shown to reduce chromosomal abberations in patients with multiple sclerosis. Metenkefalin, along with tridecactide, are under investigation as an immunomodulatory therapy for moderate to severe COVID-19.
Background
Metenkefalin is an endogenous opioid and beta-endorphin. It has been shown to reduce chromosomal abberations in patients with multiple sclerosis. Metenkefalin, along with tridecactide, are under investigation as an immunomodulatory therapy for moderate to severe COVID-19.
Indication
Metenkefalin is indicated in Bosnia for the treatment of relapsing-remitting multiple sclerosis.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.